View More Recent Stories

Jul 8, 2016 04:05PM ENGOT and TESARO Partnership Generates Positive Data From ENGOT-OV16/NOVA Phase 3 Trial
Jun 29, 2016 07:02AM TESARO (TSRO) Phase 3 NOVA Trial of Niraparib Achieves Primary Endpoint
Jun 29, 2016 07:00AM TESARO’s Niraparib Significantly Improved Progression-Free Survival for Patients With Ovarian Cancer in Both Cohorts of the Phase 3 NOVA Trial
May 19, 2016 05:46PM TESARO Congratulates Dr. Mary Lynne Hedley on Being Named Life Science "Entrepreneur of the Year” by the New England Venture Capital Association
Apr 6, 2016 07:05AM Janssen Biotech (JNJ) Enters License Agreement with TESARO (TSRO) for Niraparib
Feb 25, 2016 04:05PM TESARO Announces Definitive Agreement for $155 Million Private Placement
Dec 16, 2015 07:00AM Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance
May 30, 2015 02:00PM TESARO and Merck to Collaborate on a Combination Study of Niraparib and KEYTRUDA(R) (Pembrolizumab)
May 12, 2014 09:29AM Pre-Open Stock Movers 5/12: (TSRO) (PF) (GOGO) Higher; (HSH) (AMRN) (OMC) Lower (more...)
Dec 24, 2013 09:22AM Pre-Open Stock Movers 12/24: (ATOS) (TLSA) (TWTR) Higher; (CAMP) (GLUU) (DDD) Lower (more...)
View More Recent Stories